company. The company is focused on building componentized, reusable software
frameworks. It has built and deployed 2 frameworks and currently has a third framework in
beta testing at 10 separate companies.
Technology/Proprietary Rights DeCAF framework process in
research stage for rights protection.
Market Opportunities The company has identified the software
developer and healthcare markets as targets for the DeCAF and Remote Monitoring System
(RMS) products respectively.
The software market consists of 2 million developers, of which 500K are Java
developers. This market is growing at a rate of 15,000 per month. This growth, combined
with the benefits to the developer of including the DeCAF tool in their software
applications supports income projections of $34.7M in the next 2 years.
In recent years the trillion dollar healthcare market has experienced unprecedented
financial controls and restrictions. These restrictions have come from insurance
providers, HMOs and managed care companies. These organizations have influenced
every level of care and have forced the traditional vendors to look elsewhere for growth
segments in this market. The US Congress, Hewlett Packard (HP), Johnson and Johnson
(J&J) and Intel have all identified the long term, post acute segment as the future
growth market. The RMS product allows the healthcare delivery systems to provide cost
effective post and pre- acute care. These factors support projected revenues of $3.6M by
year end 2000.
Marketing/Sales and Distribution The DeCAF framework provides
developers with a means to build business level applications using design patterns. The
product is to be sold through a direct sales force, Public Relations campaign and Value
The RMS healthcare application is built on one of their frameworks. The product was
unveiled in March 1997 in Tokyo Japan and is currently deployed in a telemedicine pilot
project at Kurosawa hospital in Nagano Japan. The RMS product is promoted by Tandem
Computer Japan as their defacto standard for healthcare. It uses an NEC device to gather
patient vital sign information from remote locations in real time. The system disseminates
the information to the appropriate healthcare professional in a redundant, fault tolerant
manner to ensure safety.
Competition Software developers: Vitria, Talarian and Tibco.
Telemedicine: J&J and HP.
Manufacturing The RMS product is complete. The DeCAF product is
in beta testing.
Financial Information The company has invested $2M and 8 1/2
man years to develop its two products. Product development was funded through the Japanese
telemedicine project, consulting services, personal and bank loans. Revenues for 1997 and
1996 are $432,000 and $445,000 respectively.